Cavco Industries Reports Fiscal 2015 First Quarter Results

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Cavco Industries Reports Fiscal 2015 First Quarter Results

PHOENIX, July 31, 2014 (GLOBE NEWSWIRE) -- Cavco Industries, Inc. (Nasdaq: CVCO ) today announced financial results for the first quarter ended June 28, 2014 of its fiscal year 2015.

Net revenue for the first quarter of fiscal 2015 totaled $139.2 million, up 3.9% from $134.0 million for the first quarter of fiscal year 2014. Net income for the fiscal 2015 first quarter was $5.8 million compared to $3.9 million reported in the same quarter one year ago.

Net income attributable to Cavco stockholders for the fiscal 2015 first quarter was $5.8 million, compared to net income of $1.8 million reported in the same quarter of the prior year. The prior year amount was after deduction for the $2.0 million of net income attributable to redeemable noncontrolling interest. As previously reported, Cavco purchased the noncontrolling interest during the second quarter of fiscal year 2014 and now owns 100% of its consolidated subsidiaries; accordingly, all of the fiscal 2015 first quarter consolidated net income is attributable to Cavco stockholders. Net income per share attributable to Cavco stockholders based on basic and diluted weighted average shares outstanding for the quarter ended June 28, 2014 was $0.65 and $0.64, respectively, versus basic and diluted net income per share attributable to Cavco stockholders of $0.26 for the prior year period.

Commenting on the quarter, Joseph Stegmayer, Chairman, President and Chief Executive Officer, said, "We are pleased to begin the new fiscal year with improved results in the first fiscal quarter compared to the same quarter last year. It is important to note, however, that net income attributable to Cavco Stockholders in last year's first quarter excluded approximately $2 million of net income attributable to noncontrolling interests, which accounts for approximately one-half of the improvement. Overall, Cavco benefited from sequentially higher home sales volume and increased regular order backlog during the first fiscal quarter. The larger backlog level enhanced production efficiencies in our systems-based homebuilding operations."

Mr. Stegmayer continued, "Cavco's outlook continues to be positive. We believe the geographic markets in which we operate have good potential for increased manufactured housing demand. However, improvements in important macro-economic factors such as consumer confidence and employment levels continue to be slower and less consistent than needed to foster greater household formation rates and home ownership levels."

Mr. Stegmayer concluded, "Cavco's home distribution network is made up of independent and company-owned locations that work collaboratively with our homebuilding production teams that have the experience to be flexible and adaptive to local building requirements and preferences. We consistently develop new and innovative product designs that appeal to a broad range of customer housing trends. Combined with the additional product offerings and services of our finance and insurance businesses, we believe Cavco is well positioned for future growth."

Cavco's management will hold a conference call to review these results tomorrow, August 1, 2014, at 12:00 noon (Eastern Time). Interested parties can access a live webcast of the conference call on the Internet at www.cavco.com under the Investor Relations link. An archive of the webcast and presentation will be available for 90 days at www.cavco.com under the Investor Relations link.

Cavco Industries, Inc., headquartered in Phoenix, Arizona, designs and produces factory-built housing products primarily distributed through a network of independent and company-owned retailers. The Company is a leading producer of manufactured homes in the United States, based on reported wholesale shipments, marketed under a variety of brand names including Cavco Homes, Fleetwood Homes and Palm Harbor Homes. The Company is also a leading builder of park model homes, vacation cabins and systems-built commercial structures, as well as modular homes built primarily under the Nationwide Homes brand. Cavco's mortgage subsidiary, CountryPlace, is an approved Fannie Mae and Ginnie Mae seller/servicer and offers conforming mortgages to purchasers of factory-built and site-built homes. Its insurance subsidiary, Standard Casualty, provides property and casualty insurance to owners of manufactured homes.

Certain statements contained in this release are forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Securities and Exchange Act of 1934 and the Private Securities Litigation Reform Act of 1995. In general, all statements that are not historical in nature are forward-looking. Forward-looking statements are typically included, for example, in discussions regarding the manufactured housing and site-built housing industries; our financial performance and operating results; and the expected effect of certain risks and uncertainties on our business, financial condition and results of operations. All forward-looking statements are subject to risks and uncertainties, many of which are beyond our control. As a result, our actual results or performance may differ materially from anticipated results or performance. Factors that could cause such differences to occur include, but are not limited to: adverse industry conditions; our ability to successfully integrate Fleetwood Homes, Palm Harbor, CountryPlace, Standard Casualty and any future acquisition or attain the anticipated benefits of such acquisition; the risk that past acquisitions and any future acquisition may adversely impact our liquidity; entry into new lines of business, namely manufactured housing consumer finance and insurance; a constrained consumer financing market; curtailment of available financing for retailers in the manufactured housing industry; our participation in certain wholesale and retail financing programs for the purchase of our products by industry distributors and consumers may expose us to additional risk of credit loss; significant warranty and construction defect claims; our contingent repurchase obligations related to wholesale financing; market forces and declining housing demand; a write-off of all or part of our goodwill; the cyclical and seasonal nature of our business; limitations on our ability to raise capital; competition; our ability to maintain relationships with independent distributors; our business and operations being concentrated in certain geographic regions; labor shortages; pricing and availability of raw materials; unfavorable zoning ordinances; general deterioration in economic conditions and continued turmoil in the credit markets; increased costs of healthcare benefits for employees; governmental and regulatory disruption; information technology failures and data security breaches; together with all of the other risks described in our filings with the Securities and Exchange Commission. Readers are specifically referred to the Risk Factors described in Item 1A of the 2014 Form 10-K, as may be amended from time to time, which identify important risks that could cause actual results to differ from those contained in the forward-looking statements. Cavco expressly disclaims any obligation to update any forward-looking statements contained in this release, whether as a result of new information, future events or otherwise. Investors should not place any reliance on any such forward-looking statements.

CAVCO INDUSTRIES, INC.
CONSOLIDATED BALANCE SHEETS
(Dollars in thousands, except per share amounts)
     
  June 28, March 29,
  2014 2014
ASSETS (Unaudited)
Current assets:    
Cash and cash equivalents $73,604 $72,949
Restricted cash, current 7,045 7,213
Accounts receivable, net 25,033 20,766
Short-term investments 8,997 8,289
Current portion of consumer loans receivable, net 20,782 19,893
Current portion of inventory finance notes receivable, net 2,760 2,941
Inventories 73,591 69,729
Assets held for sale 859 1,130
Prepaid expenses and other current assets 12,698 12,623
Deferred income taxes, current 9,403 12,313
Total current assets 234,772 227,846
Restricted cash 1,210 1,188
Investments 16,617 17,165
Consumer loans receivable, net 77,420 78,391
Inventory finance notes receivable, net 18,758 18,367
Property, plant and equipment, net 47,985 48,227
Goodwill and other intangibles, net 77,710 78,055
Total assets $474,472 $469,239
     
LIABILITIES AND STOCKHOLDERS' EQUITY    
Current liabilities:    
Accounts payable $15,670 $15,287
Accrued liabilities 72,992 73,519
Current portion of securitized financings 10,155 10,187
Total current liabilities 98,817 98,993
Securitized financings 58,775 59,865
Deferred income taxes 19,997 19,948
Stockholders' equity:    
Preferred stock, $.01 par value; 1,000,000 shares authorized; No shares issued or outstanding — —
Common stock, $.01 par value; 20,000,000 shares authorized; Outstanding 8,849,824 and 8,844,824 shares, respectively 88 88
Additional paid-in capital 232,604 232,081
Retained earnings 63,587 57,828
Accumulated other comprehensive income 604 436
Total stockholders' equity 296,883 290,433
Total liabilities and stockholders' equity $474,472 $469,239
 
CAVCO INDUSTRIES, INC.
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME
(Dollars in thousands, except per share amounts)
(Unaudited)
     
  Three Months Ended
  June 28, June 29,
  2014 2013
Net revenue $139,164 $133,987
Cost of sales 107,446 104,589
Gross profit 31,718 29,398
Selling, general and administrative expenses 22,208 22,480
Income from operations 9,510 6,918
Interest expense (1,176) (1,254)
Other income 608 375
Income before income taxes 8,942 6,039
Income tax expense (3,183) (2,178)
Net income 5,759 3,861
Less: net income attributable to redeemable noncontrolling interest — 2,035
Net income attributable to Cavco common stockholders $5,759 $1,826
     
Comprehensive income:    
Net income $5,759 $3,861
Unrealized gain (loss) on available-for-sale securities, net of tax 168 (142)
Comprehensive income 5,927 3,719
Comprehensive income attributable to redeemable noncontrolling interest — 1,964
Comprehensive income attributable to Cavco common stockholders $5,927 $1,755
     
Net income per share attributable to Cavco common stockholders:    
Basic $0.65 $0.26
Diluted $0.64 $0.26
Weighted average shares outstanding:    
Basic 8,848,157 6,968,173
Diluted 9,012,296 7,049,234
 
CAVCO INDUSTRIES, INC.
OTHER OPERATING DATA
(Dollars in thousands)
(Unaudited)
     
  Three Months Ended
  June 28, June 29,
  2014 2013
Net revenue:    
Factory-built housing $126,265 $122,252
Financial services 12,899 11,735
Total net revenue $139,164 $133,987
     
Capital expenditures $410 $386
Depreciation $639 $616
Amortization of other intangibles $345 $345
     
Factory-built homes sold:    
by Company-owned retail sales centers 533 553
to independent retailers, builders, communities & developers 1,906 1,805
Total factory-built homes sold 2,439 2,358

Joseph Stegmayer Chairman and CEO Daniel Urness CFO and Treasurer Phone: 602-256-6263 On the Internet: www.cavco.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

InstaHeat 35K: FOGATTI Offers Upgraded RV Furnace Control

Updated Category News Views 94

Winter RV Trips Just Got Cozier There's nothing quite like hitting the open road in an RV during the winter months. But let's face it, nobody wants to return to a cabin that's as frigid as the great outdoors. Here's where FOGATTI steps up its game with the InstaHeat Ultra 35K RV Furnace. They’ve tinkered with the thermostat to iron out more precise control, just in time...

Continue Reading
Uber Data Breach: Class Action Investigation Begins

Updated Category News Views 202

When Tech Meets Trouble: Uber's Data Breach Picture this: the hum of Uber rides weaving through your city, drivers none the wiser that personal info has been pried from the vaults thanks to their tech partner, Fireworks AI. Uber, folks, is in hot water once again. This isn’t just another tech hiccup; it's a legal whirlwind brewing up courtesy of Edelson Lechtzin LLP, a...

Continue Reading
Beef 'O' Brady's Expands Into Tuscaloosa Market

Updated Category News Views 91

A New Player in Town: Beef 'O' Brady's Lands in Tuscaloosa Listen up, sports fans and pub grub lovers of Tuscaloosa! Beef 'O' Brady's just kicked down the doors and expanded its reach, opening a location smack on McFarland Boulevard. The place threw open its doors on October 26 and is set to make waves in the local scene, driven by the dedicated hands of Mitul Patel and...

Continue Reading
KINGRVER Boosts RV Comfort with New Water Heater Lineup

Updated Category News Views 103

An Upgrade for the Open Road In the land of RV living, comfort is king—or in this case, KINGRVER. Dropping affordable upgrades for water heaters into the world of RVs, KINGRVER's CT6 lineup is like a warm hug on a chilly campsite morning. Whether you've pulled up to a wooded retreat or parked under the vast desert sky, having dependable hot water shouldn't be a gamble....

Continue Reading
Servier's Data on Tovorafenib Shows Promise in pLGG

Updated Category News Views 570

New Light on a Critical Challenge Talk about a fight in the dark. Pediatric low-grade glioma (pLGG) is a menace that families dread, an uphill battle with odds that feel relentless. Enter Servier and its four-year updated data on OJEMDA® (tovorafenib), a beacon of hope for kids battling these tricky brain tumors. Results, presented at the SNO meeting, are fresh off the...

Continue Reading
WHO and RCSI Bahrain Join Forces on Health Initiatives

Updated Category News Views 334

Forging a Healthier Pathway In a world where healthcare challenges rise faster than my blood pressure during a stock market crash, the World Health Organization (WHO) and the Royal College of Surgeons in Ireland (RCSI) – Medical University of Bahrain have inked a deal to tackle these issues head-on. The memorandum of understanding (MoU) signed on November 15, 2026,...

Continue Reading
Ambrosia Biosciences Unveils Promising Nonclinical Metabolic Data

Updated Category News Views 136

Ambrosia's Latest Nonclinical Revelations Ambrosia Biosciences has just thrown out some major bait at ObesityWeek® 2026. The highlight? New nonclinical data profiles for two of their understudy small molecule programs—AMB-895 and AMB-131. It may sound niche, but in this sector, promising data spins heads. Their GLP-1 receptor agonist, AMB-895, and GIP receptor...

Continue Reading
Layne's Chicken Fingers Expands with Brownsville Opening

Updated Category News Views 400

Fried Delights Rise in Brownsville Never thought I'd see the day when chicken fingers felt like the main character in an epic expansion saga, but here we are. Ricki Oberoi, a veteran in the fast-food game, is pushing onward with Layne's Chicken Fingers in Brownsville, Texas. I tell you, some folks are as keen on expanding their palates as they are their portfolios....

Continue Reading
Portillo's Faces Class Action: Investor Losses at Stake

Updated Category News Views 53

Investor Tensions Rise as Portillo's Inc. Lawsuit Unfolds Investment ain't all sunshine and rainbows, and if you've been holding Portillo's Inc. (NASDAQ: PTLO) stocks between September 19, 2023, and May 4, 2026, you might find yourself caught in a storm front. We're talking shareholder class action lawsuit, folks, thanks to some allegedly misguided management moves. This...

Continue Reading
JOYEE N01 Debuts Globally with First 2,000 Deliveries

Updated Category News Views 189

JOYYE N01 Breaks into the Global Market Now, here we go, folks—a Chinese car with ambitions bigger than the Sahara. On October 28, the JOYEE N01 rolled off the assembly line and into the international scene with a lot of fanfare at FAW's Yancheng Branch. Mark my words, this isn't just another model trying to strut into the global auto arena. This event delivered the...

Continue Reading

Top 5 Most Recently Viewed Articles

Statkraft Secures Long-term Financing for Renewables Growth

Updated Category News Views 181

Statkraft's Commitment to Renewable Energy Statkraft AS is taking a significant step forward in its mission to lead in sustainable energy production. The company has recently entered into a long-term loan agreement with the Nordic Investment Bank (NIB), securing a substantial sum that will enhance its renewable energy initiatives. This strategic move underlines...

Continue Reading
New Insights on Xywav Efficacy in Narcolepsy Treatment Revealed

Updated Category News Views 469

Important Developments in Narcolepsy Treatment Jazz Pharmaceuticals plc (Nasdaq: JAZZ) released compelling Phase 4 data on Xywav (calcium, magnesium, potassium, and sodium oxybates) oral solution, focusing on its effectiveness in treating narcolepsy. The latest findings were shared at a notable sleep conference, highlighting Xywav's unique benefits, particularly for...

Continue Reading
Xerox Holdings Corporation Faces Class Action Lawsuit Update

Updated Category News Views 308

Xerox Holdings Corporation Faces Class Action Lawsuit Update As awareness grows about the evolving corporate landscape, the law firm Kirby McInerney LLP is calling attention to a class action lawsuit filed on behalf of investors in Xerox Holdings Corporation (NASDAQ:XRX). This legal action seeks to protect the rights of those who purchased securities during a specific...

Continue Reading
Dornan Law Team Enhances Defense Services with New Hire

Updated Category News Views 118

Dornan Law Team Welcomes Esteemed Attorney Ryan Crnkovich Dornan Law Team, a renowned law firm dedicated to outstanding client-centered representation, is excited to announce the addition of Attorney Ryan Crnkovich to its team. With a rich background in criminal defense, military justice, and federal law, Crnkovich enhances the firm's ability to provide top-tier advocacy....

Continue Reading
Novo's Research Unlocks New Insights into Food Noise

Updated Category News Views 637

Unpacking the Science Behind Food Noise When folks think about losing weight, most picture shedding pounds and fitting into those elusive smaller jeans. But get this—there’s a curveball called ‘food noise’ that’s making waves in obesity treatment. Novo Nordisk’s semaglutide injections are shaking things up, cutting down on those persistent thoughts about food....

Continue Reading